iBio, Inc. (NYSEAMERICAN:IBIO – Get Rating) was the recipient of a significant decrease in short interest in the month of March. As of March 31st, there was short interest totalling 1,140,000 shares, a decrease of 16.2% from the March 15th total of 1,360,000 shares. Approximately 9.5% of the shares of the stock are sold short. […]
iBio, Inc. (NYSEAMERICAN:IBIO – Get Rating) saw a large drop in short interest in March. As of March 31st, there was short interest totalling 1,140,000 shares, a drop of 16.2% from the March 15th total of 1,360,000 shares. Currently, 9.5% of the shares of the company are sold short. Based on an average daily volume […]
iBio, Inc. (NYSEAMERICAN:IBIO – Get Rating) insider Martin Brenner sold 5,213 shares of the company’s stock in a transaction dated Thursday, March 23rd. The shares were sold at an average price of $2.13, for a total value of $11,103.69. Following the completion of the sale, the insider now owns 216,159 shares of the company’s stock, […]
AriBio Co., Ltd. announced that David Greeley MD, Chief Medical Officer at AriBio, will present biomarker data from the completed phase 2 study in patients with mild to moderate Alzheimer's disease